Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Generally well-tolerated in research settings Mild nausea with higher doses Injection site redness or discomfort Rare: Dizziness or lightheadedness Potential effect on blood pressure (monitor if hypertensive) BPC-157 (Oral) is banned from 503A compounding pharmacies
Fast & Secure Shipping Dispatched with temperature-appropriate packaging
Gastrointestinal support: BPC-157's origin is in gastric research, and the earliest published studies focused on its potential protective relationship with gastrointestinal tissue
This helped to show that NNMT is a key target in metabolic research. Neelakantan and colleagues then expanded research involving small-molecule NNMT inhibitors
US$ 22.02
US$ 21.64
US$ 22.83
US$ 28.32
US$ 22.19
US$ 24.95
US$ 29.89
US$ 21.83
US$ 20.03
